Exondys 51 (Eteplirsen)
- Medicine Name: Exondys 51
- Generic Name: Eteplirsen
- Dosage Form & Strength: Injection: 100 mg/2 mL (50 mg/mL) & 500 mg/10 mL (50 mg/mL) solution in a single-dose vial
- Manufactured By: Sarepta Therapeutics, Inc.
Exondys 51 is an antisense oligonucleotide used for the treatment of Duchenne muscular dystrophy (DMD) in those who have a confirmed mutation of the DMD gene that can be treated by exon 51 skipping.
Recommended Dosage: Supplied as Injection 100 mg/2 mL (50 mg/mL) and 500 mg/10 mL (50 mg/mL) solution in a single-dose vial, the recommended dose of Exondys 51 injection is 30 mg per kg administered once weekly as a 35-60 minute intravenous infusion through an in-line 0.2 micron filter. Topical anesthetic cream may be considered at the infusion site before administration of this medication (EXONDYS 51).
If any dose of this medicinal product is missed, it may be administered as quickly as possible after the scheduled time.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.